Insmed Incorporated (LON:0JAV)
London · Delayed Price · Currency is GBP · Price in USD 173.43
+4.42 (2.62%)
Jan 9, 2026, 5:02 PM GMT
Insmed Market Cap
Insmed has a market cap or net worth of 28 billion as of January 9, 2026. Its market cap has increased by 177.43% in one year.
Market Cap
28.00B
Enterprise Value
27.29B
Revenue
332.56M
Ranking
n/a
PE Ratio
n/a
Stock Price
173.43
Market Cap Chart
Since June 1, 2000, Insmed's market cap has increased from 10.71M to 28.00B, an increase of 261,296.53%. That is a compound annual growth rate of 35.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 28.00B | 1.51% |
| Dec 31, 2025 | 27.58B | 179.53% |
| Dec 31, 2024 | 9.87B | 183.45% |
| Dec 29, 2023 | 3.48B | 54.93% |
| Dec 30, 2022 | 2.25B | -5.66% |
| Dec 31, 2021 | 2.38B | -4.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 220.48B |
| GSK plc | 75.67B |
| Haleon | 32.73B |
| Smith & Nephew | 10.69B |
| Convatec Group | 4.80B |
| Hikma Pharmaceuticals | 3.49B |
| HUTCHMED (China) | 1.87B |
| Genus | 1.70B |